About this trial
Introduced in 1930, photoplethysmography techniques presented the possibility of measuring SpO2 and heart rates (HR) using the absorption of light by the blood to define these signals. In recent years, a new approach to photoplethysmography to measure physiological parameters without contact has been developed. This technique, called remote Photoplethysmography Imaging (rPPG), uses the different Red - Green - Blue color spectra at a skin captured by the camera video to determine a plethysmography signal. However, it has never been studied in pediatric patients. The objective is to evaluate the remote photoplethysmography technology to measure vital signs in pediatrics
Eligibility criteria
Qualifiers
Children under 18 and over 3 years of age
Any reason for consultation or hospitalization
Written and signed informed consent from one parent or the person with parental authority,
Membership of a social security scheme
Disqualifiers
Patient with a neurocognitive disorder
Patient in immediate vital distress,
Known cardiac arrhythmia,
Scleroderma
Trial design
Treatments tested in this trial
- Remote photoplethysmography for physiological parameters